| ●Editorial | Tsubaki H | 352-3 | Full text | ||
| ●Data science from the view of the Regulatory Science and Open Science: Theory and human resource development ～Pre-symposium for the establishment of Interfaculty Initiative in Regulatory Science of Biomedical Science and Engineering, Gunma University～ Organized by Gunma University Cooperated by The Institute of Statistical Mathematics | 355-428 | Abstract | |||
| Opening Remarks | Hayashi K | 359-60 | |||
| ・Part 1: Data Science from the view of Regulatory Science | |||||
| Reflecting upon the regulatory science and ethics pursued by the Risk Research Network of the Institute of Statistical Mathematics | Tsubaki H | 361-5 | |||
| Regulatory Science Education at Graduate School of Gunma University | Yuminaka Y | 366-73 | |||
| Patient and Public Involvement and educational program development required for cancer research: New human resource development from a regulatory science perspective | Katayama K | 374-8 | |||
| Designated Remarks | Ideno Y | 379 | |||
| Open Discussion | 380-1 | ||||
| ・Part 2: Data Science from the view of Open Science | |||||
| The open science and its enemies: the era of meta-scientific renaissance | Saio T | 382-90 | Full text | ||
| Global trends of policy development toward open science: bioethical perspective | Kurihara C | 391-409 | Full text | ||
| Clinical Trial Data Sharing/Utilization trends and company initiatives | Kato T | 410-8 | Full text | ||
| Designated remarks from the view of patient and public | Murakami T，Suzuki K | 419-22 | |||
| Open Discussion | 423-6 | ||||
| Closing Remarks | Hanaya M，Tsubaki H， Hayashi K | 427-8 | |||
| ●Articles | |||||
| Validity Issues in the Yaju-Tsubaki Paper and Subsequent Articles What is the variable“ Study Period”? | Suzuki S | 429-46 | Full text | ||
| Consideration for Approving Associations between COVID-19 Vaccines and Cerebral and Cardiovascular Disease by the Ministry of Health, Labour and Welfare in Japan | Suzumura Y | 447-58 | Full text | ||
| Adult attention-deficit hyperactivity disorder (ADHD) revisited: with differential diagnoses of older adult ADHD | Saio T | 459-70 | Abstract | ||
| A preliminary review of Health Technology Assessment in palliative care utilizing Digital Health Technologies | Sakai M | 471-8 | Abstract | ||
| ●Article and translation | |||||
| Side effects of COVID-19 vaccines: Academic reports presented at medical conferences in Japan and a PubMed Survey | Konishi N，Hirai Y， Hikota H，et al． | 479-521 | Full text | ||
| Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues | Polykretis P，Donzelli A， Lindsay JC，et al． （Trans. by MediTRANS） | 523-34 | Full text | ||
| Note to Japanese translation | Fukushima M，Hirai Y | 535 | Full text | ||
| ●Instructions for authors［Japanese］＆［English］ | 537-45 | Full text | |||
| ●Editor’s note | Hayashi K | 547 | Full text | ||